The adverse health effects of cannabis use: What are they, and what are their implications for policy?

International Journal of Drug Policy

Volumn 20, Issue 6, 2009, Pages 458-466

  Hall, Wayne ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adverse health effects; Cannabis; Public policy

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; TETRAHYDROCANNABINOL;

ACCIDENT PRONENESS; ALCOHOLISM; AUSTRALIA; CANNABIS ADDICTION; CANNABIS SMOKING; CARCINOGENICITY; CARDIOVASCULAR DISEASE; COCAINE DEPENDENCE; DRUG LEGISLATION; EDUCATION; HEROIN DEPENDENCE; HUMAN; INTOXICATION; MUTAGENICITY; NONHUMAN; POLICY; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY FAILURE; SHORT SURVEY; TRAFFIC ACCIDENT;

EID: 70349417905     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.02.013     Document Type: Short Survey

References (165)

1. Aceto M., Scates S., lowe A., and Martin B. Dependence studies on delta-9-tetrahydrocannabinol: Studies on precipitated and abrupt withdrawal. Journal of Pharmacology and Experimental Therapeutics 278 (1996) 1290-1295
2. Adams I.B., and Martin B.R. Cannabis: Pharmacology and toxicology in animals and humans. Addiction 91 11 (1996) 1585-1614
3. AIHW. Closed treatment episodes: Client profile by principal drug of concern, AODTS-NMDS 2005-05 (2006), Australian Institute of Health and Welfare, Canberra
4. Ajdacic-Gross V., Lauber C., Warnke I., Haker H., Murray R.M., and Rossler W. Changing incidence of psychotic disorders among the young in Zurich. Schizophrenia Research 95 1-3 (2007) 9-18
5. Aldington S., Harwood M., Cox B., Weatherall M., Beckert L., Hansell A., et al. Cannabis use and risk of lung cancer: A case-control study. European Respiratory Journal 31 2 (2008) 280-286
6. Aldington S., Williams M., Nowitz M., Weatherall M., Pritchard A., McNaughton A., et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 62 12 (2007) 1058-1063
7. Andreasson S., Engstrom A., Allebeck P., and Rydberg U. Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet 2 8574 (1987) 1483-1486
8. Anthony J.C. The epidemiology of cannabis dependence. In: Roffman R.A., and Stephens R.S. (Eds). Cannabis dependence: Its nature, consequences and treatment (2006), Cambridge University Press, Cambridge, UK 58-105
9. Anthony J.C., and Helzer J.E. Syndromes of drug abuse and dependence. In: Robins L.N., and Regier D.A. (Eds). Psychiatric disorders in America: The epidemiologic catchment area (1991), Free Press, New York 116-154
10. Anthony J.C., Warner L., and Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2 3 (1994) 244-268
11. Aronow W., and Cassidy J. Effect of marihuana and placebo marihuana smoking on angina pectoris. New England Journal of Medicine 291 (1974) 65-67
12. Aronow W., and Cassidy J. Effect of smoking marijuana and of a high nicotine cigarette on angina pectoris. Clinical Pharmacology and Therapeutics 17 (1975) 549-554
13. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., and Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ 325 7374 (2002) 1212-1213
14. Asbridge M., Poulin C., and Donato A. Motor vehicle collision risk and driving under the influence of cannabis: Evidence from adolescents in Atlantic Canada. Accident Analysis and Prevention 37 6 (2005) 1025-1034
15. Bates M.N., and Blakely T.A. Role of cannabis in motor vehicle crashes. Epidemiologic Reviews 21 (1999) 222-232
16. Bilder R., Volavka J., Lachman H., and Grace A. The catechol-O-methyltransferase (COMT) polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29 (2004) 1943-1961
17. In: Bonnie R.J., Stratton K., and Wallace A.L. (Eds). Ending the tobacco problem: A blue-print for the nation (2007), The National Academies Press, Washington, DC
18. Boydell J., van Os J., Caspi A., Kennedy N., Giouroukou E., Fearon P., et al. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychological Medicine 36 10 (2006) 1441-1446
19. Brereton D. The history and politics of prohibition. In: Stokes G., Chalk P., and Gillen K. (Eds). Drugs and democracy: In search of new directions (2000), Melbourne University Press, Melbourne 85-97
20. Budney A.J., and Hughes J.R. The cannabis withdrawal syndrome. Current Opinion in Psychiatry 19 3 (2006) 233-238
21. Budney A.J., Hughes J.R., Moore B.A., and Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry 161 11 (2004) 1967-1977
22. Budney A.J., Novy P.L., and Hughes J.R. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 94 9 (1999) 1311-1322
23. Cadoni C., Pisanu A., Solinas M., Acquas E., and Di Chiara G. Behavioural sensitization after repeated exposure to [Delta]9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158 3 (2001) 259-266
24. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57 10 (2005) 1117-1127
25. Chait L.D., and Pierri J. Effects of smoked marijuana on human performance: A critical review. In: Murphy L.B., and Bartke A. (Eds). Marijuana/cannabinoids: Neurobiology and neurophysiology (1992), CRC Press, Boca Raton, FL 387-424
26. Chesher G., and Hall W.D. Effects of cannabis on the cardiovascular and gastrointestinal systems. In: Kalant H., Corrigall W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto 435-458
27. Coffey C., Carlin J.B., Lynskey M.T., Li N., and Patton G.C. Adolescent precursors of cannabis dependence: Findings from the Victorian Adolescent Health Cohort Study. British Journal of Psychiatry 182 (2003) 330-336
28. Cohen S. The 94-day cannabis study. Annals of the New York Academy of Sciences 282 (1976) 110-211
29. Compton D.R., Dewey W.L., and Martin B.R. Cannabis dependence and tolerance production. Advances in Alcohol and Substance Abuse 9 1-2 (1990) 129-147
30. Cook S.A., Lowe J.A., and Martin B.R. CB1 receptor antagonist precipitates withdrawal in mice exposed to delta9-tetrahydrocannabinol. Journal of Pharmacology and Experimental Therapeutics 285 3 (1998) 1150-1156
31. Copeland J., Swift W., and Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. Journal of Substance Abuse Treatment 20 1 (2001) 45-52
32. D'Souza D.C. Cannabinoids and psychosis. International Review of Neurobiology 78 (2007) 289-326
33. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry 57 6 (2005) 594-608
34. D'Souza D.C., Cho H.S., Perry E., and Krystal J.H. Cannabinoid 'model' psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. In: Castle D.J., and Murray R.M. (Eds). Marijuana and madness (2004), Cambridge University Press, Cambridge, UK 142-165
35. Degenhardt L., and Hall W.D. The association between psychosis and problematical drug use among Australian adults: Findings from the National Survey of Mental Health and Well-being. Psychological Medicine 31 4 (2001) 659-668
36. Degenhardt L., Hall W.D., and Lynskey M.T. Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence 71 1 (2003) 37-48
37. Dennis M., Babor T.F., Roebuck M.C., and Donaldson J. Changing the focus: The case for recognizing and treating cannabis use disorders. Addiction 97 (2002) 4-15
38. Donovan J.E., and Jessor R. Problem drinking and the dimension of involvement with drugs: A Guttman scalogram analysis of adolescent drug use. American Journal of Public Health 73 5 (1983) 543-552
39. Donovan J.E., and Jessor R. Structure of problem behavior in adolescence and young adulthood. Journal of Consulting and Clinical Psychology 53 6 (1985) 890-904
40. Duncan S.C., Duncan T.E., Biglan A., and Ary D. Contributions of the social context to the development of adolescent substance use: A multivariate latent growth modeling approach. Drug and Alcohol Dependence 50 1 (1998) 57-71
41. Dutch National Alcohol and Drug Information System. Treatment demand of cannabis clients in outpatient addiction care in the Netherlands (1994-2001). LADIS Bulletin (2004) (April)
42. Ellickson P., Bui K., Bell R., and McGuigan K.A. Does early drug use increase the risk of dropping out of high school?. Journal of Drug Issues 28 2 (1998) 357-380
43. ElSohly M.A., Ross S.A., Mehmedic Z., Arafat R., Yi B., and Banahan B.F. Potency trends of delta(9)-THC and other cannabinoids in confiscated marijuana from 1980-1997. Journal of Forensic Sciences 45 1 (2000) 24-30
44. EMCDDA (2003). Annual report 2003: The state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.
45. EMCDDA. (2004). EMCDDA Insights: An overview of cannabis potency in Europe. Luxembourg: Office for Official Publications of the European Communities.
46. Fergusson D.M., Boden J.M., and Horwood L.J. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 101 4 (2006) 556-569
47. Fergusson D.M., Horwood J.L., and Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 33 (2003) 15-21
48. Fergusson D.M., and Horwood L.J. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 92 3 (1997) 279-296
49. Fergusson D.M., and Horwood L.J. Prospective childhood predictors of deviant peer affiliations in adolescence. Journal of Child Psychology and Psychiatry and Allied Disciplines 40 4 (1999) 581-592
50. Fergusson D.M., and Horwood L.J. Does cannabis use encourage other forms of illicit drug use?. Addiction 95 4 (2000) 505-520
51. Fergusson D.M., Horwood L.J., and Ridder E.M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100 3 (2005) 354-366
52. Fergusson D.M., Horword L.J., and Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 97 (2002) 1123-1135
53. Fergusson D.M., Lynskey M.T., and Horwood L.J. The short-term consequences of early onset cannabis use. Journal of Abnormal Child Psychology 24 4 (1996) 499-512
54. Gable R.S. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 99 (2004) 686-696
55. Gardner E. Cannabinoid interaction with brain reward systems. In: Nahas G., Sutin K., Harvey D., and Agurell S. (Eds). Marihuana and medicine (1999), Humana Press, Towa, NJ 187-205
56. Gerberich S.G., Sidney S., Braun B.L., Tekawa I.S., Tolan K.K., and Quesenberry C.P. Marijuana use and injury events resulting in hospitalization. Annals of Epidemiology 13 4 (2003) 230-237
57. Gottschalk L., Aronow W., and Prakash R. Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological and cardiovascular functioning in angina patients. Biological Psychiatry 12 2 (1977) 255-266
58. Grotenhermen F., Leson G., Berghaus G., Drummer O.H., Kruger H.P., Longo M., et al. Developing limits for driving under cannabis. Addiction 102 12 (2007) 1910-1917
59. Hall W.D. The public health significance of cannabis use in Australia. Australian Journal of Public Health 19 3 (1995) 235-242
60. Hall W.D. The recent Australian debate about the prohibition on cannabis use. Addiction (1997) 1109-1115
61. Hall W.D. Assessing the health and psychological effects of cannabis use. In: Kalant H., Corrigall W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto 1-17
62. Hall W.D. Cannabis use and the mental health of young people. Australian and New Zealand Journal of Psychiatry 40 2 (2006) 105-113
63. Hall W.D. A cautious case for cannabis depenalization. In: Earleywine M. (Ed). Pot politics: Marijuana and the costs of prohibition (2007), Oxford University Press 91-112
64. Hall W.D., Degenhardt L., and Lynskey M.T. The health and psychological effects of cannabis use (National Drug Strategy Monograph No. 44) (2001), Commonwealth Department of Health and Aged Care, Canberra
65. Hall W.D., and Lynskey M.T. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review 24 1 (2005) 39-48
66. Hall W.D., and MacPhee D. Cannabis use and cancer. Addiction 97 3 (2002) 243-247
67. Hall W.D., and Pacula R.L. Cannabis use and dependence: Public health and public policy (2003), Cambridge University Press, Cambridge, UK
68. Hall W.D., Room R., and Bondy S. Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use. In: Kalant H., Corrigal W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto 475-506
69. Hall W.D., and Swift W. The THC content of cannabis in Australia: Evidence and implications. Australian and New Zealand Journal of Public Health 24 5 (2000) 503-508
70. Hall W.D., Teesson M., Lynskey M.T., and Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-being. Addiction 94 10 (1999) 1541-1550
71. Han C., McGue M.K., and Iacono W.G. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: Univariate and multivariate behavioral genetic analyses. Addiction 94 7 (1999) 981-993
72. Hashibe M., Straif K., Tashkin D.P., Morgenstern H., Greenland S., and Zhang Z.F. Epidemiologic review of marijuana use and cancer risk. Alcohol 35 3 (2005) 265-275
73. Hashibe M., Morgenstern H., Cui Y., Tashkin D.P., Zhang Z.F., Cozen W., Mack T.M., and Greenland S. Marijuana use and the risk of lung and upper aerodigestive tract cancers: Results of a population-based case-control study. Cancer Epidemiology, Biomarkers and Prevention 15 10 (2006) 1829-1834
74. Hawkins J.D., Catalano R.F., and Miller J.Y. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychological Bulletin 112 1 (1992) 64-105
75. Henningfield J.E., Benowitz N.L., Slade J., Houston T.P., Davis R.M., and Deitchman S.D. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tobacco Control 7 3 (1998) 281-293
76. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330 7481 (2004) 11
77. Hickman M., Vickerman P., Macleod J., Kirkbride J., and Jones P.B. Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 102 4 (2007) 597-606
78. Hingson R., Heeren T., Mangione T., Morelock S., and Mucatel M. Teenage driving after using marijuana or drinking and traffic accident involvement. Journal of Safety Research 13 (1982) 33-37
79. Hsairi M., Achour N., Zouari B., Ben Romdhane H., Achour A., Maalej M., et al. Etiologic factors in primary bronchial carcinoma in Tunisia [Facteurs etiologiques du cancer bronchique primitif en Tunisie]. Tunisie Medicale 71 5 (1993) 265-268
80. Institute of Medicine. Marijuana and medicine: Assessing the science base (1999), National Academy Press, Washington, DC
81. Iversen L. The science of marijuana. 2nd ed. (2007), Oxford University Press, Oxford
82. Jessor R., and Jessor S.L. Problem behavior and psychosocial development: A longitudinal study of youth (1977), Academic Press, New York
83. Jones R.T. Cardiovascular system effects of marijuana. Journal of Clinical Pharmacology 42 Suppl. 11 (2002) 58S-63S
84. Jones R.T., Benowitz N., and Herning R.I. The 30-day trip: Clinical studies of cannabis use, tolerance and dependence. In: Braude M., and Szara S. (Eds). The pharmacology of marijuana Vol. 2 (1976), Academic Press, New York 627-642
85. Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 5 (2004) 849-863
86. Kandel D.B. Marijuana users in young adulthood. Archives of General Psychiatry 41 2 (1984) 200-209
87. Kandel D.B. Issues of sequencing of adolescent drug use and other problem behaviors. Drugs and Society 3 1-2 (1988) 55-76
88. Kandel D.B. Stages and pathways of drug involvement: Examining the gateway hypothesis (2002), Cambridge University Press, New York
89. Kandel D.B., and Davies M. Progression to regular marijuana involvement: Phenomenology and risk factors for near-daily use. In: Glantz M.D. (Ed). Vulnerability to drug abuse (1992), American Psychological Association, Washington, DC 211-253
90. Kandel D.B., Davies M., Karus D., and Yamaguchi K. The consequences in young adulthood of adolescent drug involvement: An overview. Archives of General Psychiatry 43 8 (1986) 746-754
91. Kelly E., Darke S., and Ross J. A review of drug use and driving: Epidemiology, impairment, risk factors and risk perceptions. Drug and Alcohol Review 23 3 (2004) 319-344
92. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51 1 (1994) 8-19
93. Kleiman M.A.R. Neither prohibition nor legalization: Grudging toleration in drug control policy. Daedalus 121 (1992) 53-83
94. Kouri E.M., and Pope H.G. Abstinence symptoms during withdrawal from chronic marijuana use. Experimental and Clinical Psychopharmacology 8 4 (2000) 483-492
95. Krohn M.D., Lizotte A.J., and Perez C.M. The interrelationship between substance use and precocious transitions to adult statuses. Journal of Health and Social Behavior 38 1 (1997) 87-103
96. Lamarque S., Taghzouti K., and Simon H. Chronic treatment with [Delta] 9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin: Implications for vulnerability to drug addiction. Neuropharmacology 41 1 (2001) 118-129
97. Laumon B., Gadegbeku B., Martin J.L., and Biecheler M.B. Cannabis intoxication and fatal road crashes in France: Population based case-control study. BMJ 331 7529 (2005) 1371
98. Ledent C., Valverde O., Cossu C., Petitet F., Aubert L.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 5400 (1999) 401-404
99. Lichtman A.H., Fisher J., and Martin B.R. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine. Pharmacology, Biochemistry and Behavior 69 1-2 (2001) 181-188
100. Lichtman A.H., Wiley J.L., LaVecchia K.L., Neviaser S.T., Arthur D.B., Wilson D.M., et al. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. European Journal of Pharmacology 357 2-3 (1998) 139-148
101. Lifrak P.D., McKay J.R., Rostain A., Alterman A.I., and Obrien C.P. Relationship of perceived competencies, perceived social support, and gender to substance use in young adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 36 7 (1997) 933-940
102. Llewellyn C.D., Linklater K., Bell J., Johnson N.W., and Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: A case-control study. Oral Oncology 40 3 (2004) 304-313
103. Lynskey M.T. An alternative model is feasible, but the gateway hypothesis has not been invalidated: Comments on Morral et al. Addiction 97 12 (2002) 1505-1507
104. Lynskey M.T., and Hall W.D. The effects of adolescent cannabis use on educational attainment: A review. Addiction 96 3 (2000) 433-443
105. Lynskey M.T., Heath A.C., Bucholz K.K., and Slutske W.S. Escalation of drug use in early-onset cannabis users vs. co-twin controls. Jama-Journal of the American Medical Association 289 4 (2003) 427-433
106. Lynskey M.T., White V., Hill D., Letcher T., and Hall W.D. Prevalence of illicit drug use among youth: Results from the Australian school students' alcohol and drugs survey. Australian and New Zealand Journal of Public Health 23 5 (1999) 519-524
107. MacCoun R., and Reuter P. Drug war heresies: Learning from other vices, times and places (2001), Cambridge University Press, Cambridge, UK
108. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M., et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet 363 9421 (2004) 1579-1588
109. MacPhee D. Effects of marijuana on cell nuclei: A review of the literature relating to the genotoxicity of cannabis. In: Kalant H., Corrigall W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto 435-458
110. Maldonado R. Study of cannabinoid dependence in animals. Pharmacology and Therapeutics 95 (2002) 153-164
111. Mannisto P., and Kaakkola S. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews 51 4 (2006) 593-628
112. In: Manski C.F., Pepper J.V., and Petrie C.V. (Eds). Informing America's policy on illegal drugs: What we don't know keeps hurting us (2001), National Academy Press, Washington, DC
113. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., and Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends in Pharmacological Sciences 20 7 (1999) 287-294
114. Marselos M., and Karamanakos P. Mutagenicity, developmental toxicity and carcinogeneity of cannabis. Addiction Biology 4 1 (1999) 5-12
115. McDonald D., Moore R., Norberry J., Wardlaw G., and Ballenden N. Legislative options for cannabis in Australia (National Drug Strategy Monograph No. 26) (1994), Australian Government Publishing Service, Canberra
116. McGee R., and Feehan M. Cannabis use among New Zealand adolescents. New Zealand Medical Journal 106 961 (1993) 345
117. McLaren J., Swift W., Dillon P., and Allsop S. Cannabis potency and contamination: A review of the literature. Addiction 103 7 (2008) 1100-1109
118. Mehra R., Moore B.A., Crothers K., Tetrault J., and Fiellin D.A. The association between marijuana smoking and lung cancer: A systematic review. Archives of Internal Medicine 166 13 (2006) 1359-1367
119. Mittleman M.A., Lewis R.A., Maclure M., Sherwood J.B., and Muller J.E. Triggering myocardial infarction by marijuana. Circulation 103 (2001) 2805-2809
120. Moir D., Rickert W.S., Levasseur G., Larose Y., Maertens R., White P., et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chemical Research in Toxicology 21 2 (2008) 494-502
121. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet 370 9584 (2007) 319-328
122. Morral A.R., McCaffrey D.F., and Paddock S.M. Reassessing the marijuana gateway effect. Addiction 97 12 (2002) 1493-1504
123. Murray R.M., Morrison P.D., Henquet C., and Di Forti M. Cannabis, the mind and society: The hash realities. Nature Reviews Neuroscience 8 11 (2007) 885-895
124. Nutt D., King L.A., Saulsbury W., and Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369 9566 (2007) 1047-1053
125. ONDCP (2007). Study finds highest levels of THC in U.S. marijuana to date [release]. Retrieved 21 March, 2008, from http://www.whitehousedrugpolicy.gov/news/press07/042507_2.html.
126. Osgood D.W., Johnston L.D., O'Malley P.M., and Bachman J.G. The generality of deviance in late adolescence and early adulthood. American Sociological Review 53 1 (1988) 81-93
127. Pijlman F.T., Rigter S.M., Hoek J., Goldschmidt H.M., and Niesink R.J. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addiction Biology 10 2 (2005) 171-180
128. Ramaekers J.G., Berghaus G., van Laar M., and Drummer O.H. Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence 73 2 (2004) 109-119
129. Resnick M.D., Bearman P.S., Blum R.W., Bauman K.E., Harris K.M., Jones J., et al. Protecting adolescents from harm: Findings from the National Longitudinal Study on Adolescent Health. Jama-Journal of the American Medical Association 278 10 (1997) 823-832
130. Robbe, H. W. J. (1994). Influence of marijuana on driving. Unpublished PhD. Maastricht: Institute for Human Psychopharmacology, University of Limberg.
131. Room R., Fischer B., Hall W.D., Lenton S., and Reuter P. Cannabis policy: Moving beyond stalemate. The Global Cannabis Commission Report (2008), Beckley Foundation, Oxford, UK
132. Rosenblatt K.A., Daling J.R., Chen C., Sherman K.J., and Schwartz S.M. Marijuana use and risk of oral squamous cell carcinoma. Cancer Research 64 11 (2004) 4049-4054
133. SAMHSA. Treatment episode data set (TEDS): Highlights-2002. National admissions to substance abuse treatment services (2004), Office of Applied Studies, Substance and Mental Health Services Administration, Rockville, MD
134. Selley D.A., Lichtman A.H., and Martin B.R. Integration of molecular and behavioral approaches to evaluate cannabinoid dependence. In: Maldonado R. (Ed). Molecular biology of drug addiction (2003), Humana Press, Totawa, NJ 199-220
135. Shand F., and Mattick R. Clients of treatment service agencies: May 2001 Census findings (National Drug Strategy Monograph) (2001), Commonwealth Department of Health and Ageing, Canberra
136. Sidney S. Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology 42 Suppl. 11 (2002) 64S-70S
137. Sidney S., Quesenberry Jr. C.P., Friedman G.D., and Tekawa I.S. Marijuana use and cancer incidence (California, United States). Cancer Causes and Control 8 5 (1997) 722-728
138. Sindall C. Health policy and normative analysis: Ethics, evidence and policy. In: Linn V., and Gibson B. (Eds). Evidence-based health policy: Problems and possibilities. (2003), Oxford University Press, Melbourne 80-94
139. Smart R., and Fejer D. Drug use and driving among high school students. Accident Analysis and Prevention 8 (1976) 33-38
140. Smiley A. Marijuana: On road and driving simulator studies. In: Kalant H., Corrigall W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto
141. Solowij N. Cannabis and cognitive functioning (1998), Cambridge University Press, Cambridge, UK
142. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., and Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99 10 (2004) 1333-1341
143. Stephens R.S., Roffman R.A., and Simpson E.E. Treating adult marijuana dependence-a test of the relapse prevention model. Journal of Consulting and Clinical Psychology 62 1 (1994) 92-99
144. Swift W., Hall W.D., and Copeland J. Characteristics of long-term cannabis users in Sydney, Australia. European Addiction Research 4 4 (1998) 190-197
145. Swift W., Hall W.D., and Teesson M. Cannabis use and dependence among Australian adults: Results from the National Survey of Mental Health and Well-being. Addiction 96 5 (2001) 737-748
146. Tanda G., Pontieri F.E., and Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276 5321 (1997) 2048-2050
147. Tanner J., Davies S., and O'Grady B. Whatever happened to yesterday's rebels? Longitudinal effects of youth delinquency on education and employment. Social Problems 46 2 (1999) 250-274
148. Tashkin D.P. Effects of cannabis on the respiratory system. In: Kalant H., Corrigall W., Hall W.D., and Smart R. (Eds). The health effects of cannabis (1999), Centre for Addiction and Mental Health, Toronto
149. Tashkin D.P. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Current Opinion in Pulmonary Medicine 7 (2001) 43-61
150. Tashkin D.P., Baldwin G.C., Sarafian T., Dubinett S., and Roth M.D. Respiratory and immunologic consequences of marijuana smoking. Journal of Clinical Pharmacology 42 11 (2002) 71S-81S
151. Taylor D.R., Fergusson D.M., Milne B.J., Horwood L.J., Moffitt T.E., Sears M.R., et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 97 8 (2002) 1055-1061
152. Taylor D.R., Poulton R., Moffitt T., Ramankutty P., and Sears M. The respiratory effects of cannabis dependence in young adults. Addiction 95 (2000) 1669-1677
153. Tetrault J.M., Crothers K., Moore B.A., Mehra R., Concato J., and Fiellin D.A. Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine 167 3 (2007) 221-228
154. Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence 42 3 (1996) 201-207
155. Tien A.Y., and Anthony J.C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 178 8 (1990) 473-480
156. True W.R., Heath A.C., Scherrer J.F., Xian H., Lin N., Eisen S.A., et al. Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. American Journal of Medical Genetics 88 4 (1999) 391-397
157. Tsou D., Patrick S., and Walder J. Physical withdrawal in rats tolerant to delta-9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. European Journal of Pharmacology 280 (1995) R13-R15
158. van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R., and Verdoux H. Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology 156 4 (2002) 319-327
159. Wagner F.A., and Anthony J.C. Into the world of illegal drug use: Exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. American Journal of Epidemiology 155 10 (2002) 918-925
160. Weiss C. Introduction. In: Weiss C. (Ed). Using social research in public policy making (1977), Lexington Books, Lexington, MA 1-22
161. Weiss C. Ideology, interests and information: The basis of policy positions. In: Calahan D., and Jennings B. (Eds). Ethics, the social sciences and policy analysis (1983), Plenum Press, New York 213-245
162. Wiesbeck G.A., Schuckit M.A., Kalmijn J.A., Tipp J.E., Bucholz K.K., and Smith T.L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 91 10 (1996) 1469-1478
163. Zammit S., Allebeck P., Andreasson S., Lundberg I., and Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study. BMJ 325 7374 (2002) 1199-1201
164. Zhang Z.F., Morgenstern H., Spitz M.R., Tashkin D.P., Yu G.P., Marshall J.R., et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiology Biomarkers and Prevention 8 12 (1999) 1071-1078
165. Zimmer L., and Morgan J.P. Marijuana myths, marijuana facts: A review of the scientific evidence (1997), The Lindesmith Center, New York